Behold, two troubling articles, the first on using cadavers in hotel ballrooms to practice medical procedures. The second, spotlighting a practice of Chinese physicians, who rarely disclose the diagnosis of cancer to their patients.
Other Science News
Flu season is ramping up and it will be nearing its peak in a month or two. Unfortunately, what we've learned so far is that H3N2 is the predominant circulating strain. What that tells us, using previous flu seasons dominated by that strain as a guide, is that we're probably in for a rough ride.
With President Trump's annual physical looming, what matters most? And specifically, what would it take to make a president unfit to serve?
Pollsters are always seeking our opinions and trends, and the close of 2017 was prime time for probing how we feel as we look ahead to 2018. For instance, in the "not-so-great category" what words or phrases irked the largest number of people? And then there are all those New Year's resolutions: Will we make them? Will we keep them?
We spend over $73 billion annually on state lotteries. What is that all about?
Lawyers are routinely required to solve problems that they themselves created. If something like this were to occur in any other area of life, it would be called racketeering. So beware, science: a lawsuit-happy nation turns its eyes to you.
Value-based healthcare: that's the goal. But like blind men touching an elephant, describing one part or another, what we mean by "value" depends on who we are.
What'cha gonna do when they come for you? If "they" are the officials at the Department of Justice – and you are a pharmaceutical or healthcare company or even a physician – you settle.
It's hard to feel a lot of love for Amazon right now. It used to be a great company. But it's a little disturbing that the retail giant is cutting its inventory. You can no longer buy a circumcision practice kit in Britain! What's next?
ACSH is in the business of promoting evidence-based science and debunking junk science. That rubs some people the wrong way.
Scientists cannot publish the same figure twice. Those are the rules. One group, however, tried to pull a fast one and had the same figure in eight papers. Eight! How did journal editors find out? Easy ... they emailed each other. Now, the papers are getting their due by being retracted.
FDA-approved gene therapies is atop of the list of exciting health and science advances of 2017. Following in the wake of two cancer therapies approved earlier this year, a third therapy – this time for vision – received a thumbs-up just before the arrival of 2018.